01 / Vendor Profile
NAVITAS CLINICAL RESEARCH INC Federal Contracts and Awards
UEI HA8KGRBJZNM8 · CAGE 3GM97
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $18.85M in net contract obligations to NAVITAS CLINICAL RESEARCH INC across 53 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
NAVITAS CLINICAL RESEARCH INC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$1.43M
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $2.31M | 6 | 2 | — |
| FY 2021 | $3.09M | 9 | 3 | +33.6% |
| FY 2022 | $3.15M | 10 | 2 | +2.0% |
| FY 2023 | $4.67M | 10 | 2 | +48.5% |
| FY 2024 | $2.98M | 11 | 2 | −36.2% |
| FY 2025 | $1.22M | 4 | 2 | −59.1% |
| FY 2026 | $1.43M | 3 | 2 | +17.3% |
04 / Federal Customers
Which federal agencies buy from NAVITAS CLINICAL RESEARCH INC?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $13.61M | 41 | 72.2% | |
| 7523 | $5.26M | 11 | 27.9% | |
| 1700 | -$12.2K | 1 | -0.1% |
05 / Contracting Offices
Which contracting offices buy from NAVITAS CLINICAL RESEARCH INC?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $10.31M | 22 | 54.7% | |
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $5.26M | 11 | 27.9% | |
| 75N950 | NATIONAL INSTITUTES OF HEALTH | $3.43M | 17 | 18.2% | |
| N32398 | DEPT OF THE NAVY | -$12.2K | 1 | -0.1% | |
| 75N930 | NATIONAL INSTITUTES OF HEALTH | -$127.8K | 2 | -0.7% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $9.31M | 18 | 2 | 49.4% |
| 621511 | MEDICAL LABORATORIES | $4.18M | 4 | 1 | 22.2% |
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | $3.43M | 17 | 1 | 18.2% |
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | $2.07M | 11 | 2 | 11.0% |
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | -$140.0K | 3 | 2 | -0.7% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| B599 | SPECIAL STUDIES/ANALYSIS- OTHER | $8.24M | 12 | 1 | 43.7% |
| R499 | SUPPORT- PROFESSIONAL: OTHER | $4.18M | 4 | 1 | 22.2% |
| R799 | SUPPORT- MANAGEMENT: OTHER | $3.43M | 17 | 1 | 18.2% |
| AN16 | R&D- MEDICAL: BIOMEDICAL (MANAGEMENT/SUPPORT) | $2.07M | 9 | 1 | 11.0% |
| Q301 | MEDICAL- LABORATORY TESTING | $1.07M | 6 | 1 | 5.7% |
| AN11 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $0 | 1 | 1 | 0.0% |
| AZ11 | R&D- OTHER RESEARCH AND DEVELOPMENT (BASIC RESEARCH) | $0 | 1 | 1 | 0.0% |
| AN15 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT | -$12.2K | 1 | 1 | -0.1% |
| AZ12 | R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT) | -$127.8K | 2 | 1 | -0.7% |
08 / Competition Pattern
How was NAVITAS CLINICAL RESEARCH INC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for NAVITAS CLINICAL RESEARCH INC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75D30124C19866 | Jun 12, 2026 | $1.43M | CENTERS FOR DISEASE CONTROL AND PREVENTION CDC OFFICE OF ACQUISITION SERVICES | 621511 | R499 |
10 / Interpreting the Profile
How should you evaluate NAVITAS CLINICAL RESEARCH INC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.